Crossmark

ASO Author Reflections: Global Perspectives on Index Lymph Node Surgery after Neoadjuvant Therapy for Stage III Melanoma

Published Online: 2025-12-03

Published Print: 2026-03

Authors

Novis, Elan https://orcid.org/0009-0003-0734-8309
Rautalin, Mervi

van Akkooi, Alexander C. J.
License Information

Text and Data Mining valid from 2025-12-03

Version of Record valid from 2025-12-03
More Information

Article History

Received: 11 November 2025

Accepted: 18 November 2025

First Online: 3 December 2025

Disclosure

: Alexander Christopher Jonathan van Akkooi holds honoraria or a consultancy or advisory role in Adium, Amgen, Bristol-Myers Squibb, Daiichi Sankyo, Genmab, Menarini Silicon Biosystems, Merck Serono-Pfizer, MSD Merck, Neracare, Novartis, Pierre Fabre, Provectus, Regeneron, Replimune, Sanofi, Sirius Medical, SkylineDx, and 4SC; research funding from Amgen, Merck Serono-Pfizer, and SkylineDx; and NHMRC Clinical Trials and Cohort Studies grant number 2043780.

Document is current